🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Salomé Manska

C4 Therapeutics (United States)

ORCID: 0000-0002-6345-0880

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “5-Ethynyl-2′-deoxycytidine and 5-ethynyl-2′-deoxyuridine are differentially incorporated in cells infected with HSV-1, HCMV, and KSHV viruses”.

5-Ethynyl-2′-deoxycytidine and 5-ethynyl-2′-deoxyuridine are differentially incorporated in cells infected with HSV-1, HCMV, and KSHV viruses

Journal of Biological Chemistry(2020)10.1074/jbc.ra119.012378

N/A

0DataRank · unranked

22 citations

Rionna Octaviano, Cyprian C. Rossetto, Salomé Manska

Characteristics of Immediate-Early 2 (IE2) and UL84 Proteins in UL84-Independent Strains of Human Cytomegalovirus (HCMV)

Microbiology Spectrum(2021)10.1128/spectrum.00539-21

N/A

0DataRank · unranked

9 citations

Cyprian C. Rossetto, Salomé Manska

Characterization of Human Cytomegalovirus (HCMV) Long Non-Coding RNA1.2 During Lytic Replication

Viruses(2025)10.3390/v17020149

N/A

0DataRank · unranked

0 citations

Andrew Hagemann, Janna Magana, Cyprian C. Rossetto, Subhash C. Verma, Salomé Manska